Pharmacokinetics, Safety, Tolerability of TEV-48125 in Healthy Subjects After Administration of TEV-48125

Study Title

To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

Teva Identifier

TV48125-PK-10078

ClinicalTrials.gov Identifier

NCT02673567

Study Status

Completed

Trial Condition(s)

Pharmacokinetics

Interventions

Drug: TEV-48125 - 1 | Drug: TEV-48125 - 2 | Drug: TEV-48125 - 3 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
disease icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

March 31, 2016 - February 10, 2017

Phase

Phase 1

Study Type

Interventional